"The time has come to change the rules of the game regarding non-taxable profits of international companies and tax benefits," Yair Lapid told Jeremy Levin, the chief executive officer of Israel-based Teva Pharmaceutical Industries (TEVA.TA) (TEVA.N), according to a statement.
Lapid, already feeling heat from the public for introducing new austerity measures, is looking for ways to fill a ballooning hole in Israel's 2013 budget. The government set a deficit target of 4.65 percent of gross domestic product in 2013, or about 47 billion shekels ($13 billion).
Also read: Caterpillar Says Sales Woes Could Linger
16:36 AT&T, Time Warner poised to lobby lawmakers, regulators on proposed $85-billion merger15
12:23 Lockheed Martin's quarterly profit handily beats estimates13
11:41 Caterpillar earnings: 85 cents per share, vs expected EPS of 76 cents14
16:51 Scottrade Sale Nearly Doubles Owner’s Wealth to $4 Billion11